Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor05 Nov 2025, 03:37 UTC
Video preview for Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video provides a fundamental analysis of AMD's stock, referring to its Q3 2025 revenue growth of 36% year-over-year reaching $9.2 billion, and client and gaming segment experiencing a 73% year-over-year revenue increase. It mentions AMD has a partnership with Open AI and many others. Quarter on quarter data centre revenue is at 22% and revenue growth is at 32%. The video suggests that despite the stock trading at almost 50 times 2026 earnings, with estimated 54% earnings growth in 2026, and average multiple of 35, there's still 105% upside to $513 and projects $183 per share if buying with margin of safety over the next five years.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.